Luteolin has a synergistic effect with paclitaxel, which can effectively reduce p-STAT3 in mouse breast cancer cells and induce breast tumor regression in mice injected subcutaneously with MDA-MB-231 cells together with paclitaxel (Yang et al., 2014). The gene discussed is STAT3; the disease is breast carcinoma.